Literature DB >> 21042851

Expression and signaling of formyl-peptide receptors in the brain.

Fabio Cattaneo1, Germano Guerra, Rosario Ammendola.   

Abstract

The human formyl-peptide receptor (FPR) and its variants FPRL1 and FPRL2 belong to the G-protein coupled seven transmembrane receptor (GPCR) family sensitive to pertussis toxin. FPR and FPRL1 were first detected in phagocytic leukocytes, and FPRL2 was found in monocytes and in dendritic cells. The three receptors were subsequently identified in other cell types or tissues, including neuronal cells and brain, where FPR and FPRL1 play a key role in angiogenesis, cell proliferation, protection against and cell death, as well as in neuroendocrine functions. Binding of different agonists to FPRs triggers several signaling pathways, activates NFkB and STAT3 transcriptional factors and induces the accumulation of the CDK inhibitors p21(waf1/cip1), p16(INK4) and p27(kip1). Signaling molecules, such as ERKs, JNK, PKC, p38MAPK, PLC and PLD are involved in these intracellular cascades. In this article we briefly review FPRs expression and signaling in neuronal cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21042851     DOI: 10.1007/s11064-010-0301-5

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  69 in total

1.  Expression of functional formyl peptide receptors by human astrocytoma cell lines.

Authors:  Y Le; J Hu; W Gong; W Shen; B Li; N M Dunlop; D O Halverson; D G Blair; J M Wang
Journal:  J Neuroimmunol       Date:  2000-11-01       Impact factor: 3.478

2.  Formyl peptide receptor-like proteins are a novel family of vomeronasal chemosensors.

Authors:  Stéphane Rivière; Ludivine Challet; Daniela Fluegge; Marc Spehr; Ivan Rodriguez
Journal:  Nature       Date:  2009-05-28       Impact factor: 49.962

3.  Arrestin binding to the G protein-coupled N-formyl peptide receptor is regulated by the conserved "DRY" sequence.

Authors:  T A Bennett; D C Maestas; E R Prossnitz
Journal:  J Biol Chem       Date:  2000-08-11       Impact factor: 5.157

4.  Two distinct Gi-proteins mediate formyl peptide receptor signal transduction in human leukemia (HL-60) cells.

Authors:  P Gierschik; D Sidiropoulos; K H Jakobs
Journal:  J Biol Chem       Date:  1989-12-25       Impact factor: 5.157

5.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

Authors:  M P Lambert; A K Barlow; B A Chromy; C Edwards; R Freed; M Liosatos; T E Morgan; I Rozovsky; B Trommer; K L Viola; P Wals; C Zhang; C E Finch; G A Krafft; W L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

6.  Involvement of tyrosine kinases and STAT3 in Humanin-mediated neuroprotection.

Authors:  Yuichi Hashimoto; Hiroaki Suzuki; Sadakazu Aiso; Takako Niikura; Ikuo Nishimoto; Masaaki Matsuoka
Journal:  Life Sci       Date:  2005-07-06       Impact factor: 5.037

7.  Lipoxin A4 inhibits TNF-alpha-induced production of interleukins and proliferation of rat mesangial cells.

Authors:  Sheng-Hua Wu; Chao Lu; Ling Dong; Guo-Ping Zhou; Zha-Guang He; Zi-Qing Chen
Journal:  Kidney Int       Date:  2005-07       Impact factor: 10.612

8.  Induction of the formyl peptide receptor 2 in microglia by IFN-gamma and synergy with CD40 ligand.

Authors:  Keqiang Chen; Pablo Iribarren; Jian Huang; Lingzhi Zhang; Wanghua Gong; Edward H Cho; Stephen Lockett; Nancy M Dunlop; Ji Ming Wang
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

9.  The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells.

Authors:  J Huang; K Chen; J Chen; W Gong; N M Dunlop; O M Z Howard; Y Gao; X-w Bian; J M Wang
Journal:  Br J Cancer       Date:  2010-03-02       Impact factor: 7.640

10.  A novel lipoxygenase inhibitor Nordy attenuates malignant human glioma cell responses to chemotactic and growth stimulating factors.

Authors:  Jian-hong Chen; Xiao-hong Yao; Wanghua Gong; Jinyue Hu; Xiang-dong Zhou; Keqiang Chen; Hong Liu; Yi-fang Ping; Ji Ming Wang; Xiu-wu Bian
Journal:  J Neurooncol       Date:  2007-03-22       Impact factor: 4.506

View more
  36 in total

1.  Lack of formyl peptide receptor 1 and 2 leads to more severe inflammation and higher mortality in mice with of pneumococcal meningitis.

Authors:  Sandra Oldekamp; Sebastian Pscheidl; Eugenia Kress; Oliver Soehnlein; Sandra Jansen; Thomas Pufe; Ji Ming Wang; Simone C Tauber; Lars-Ove Brandenburg
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

2.  Formyl Peptide Receptor 1-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.

Authors:  Kai Bihler; Eugenia Kress; Stefan Esser; Stella Nyamoya; Simone C Tauber; Tim Clarner; Matthias B Stope; Thomas Pufe; Lars-Ove Brandenburg
Journal:  J Mol Neurosci       Date:  2017-05-02       Impact factor: 3.444

3.  Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists.

Authors:  Maria Paola Giovannoni; Igor A Schepetkin; Agostino Cilibrizzi; Letizia Crocetti; Andrei I Khlebnikov; Claes Dahlgren; Alessia Graziano; Vittorio Dal Piaz; Liliya N Kirpotina; Serena Zerbinati; Claudia Vergelli; Mark T Quinn
Journal:  Eur J Med Chem       Date:  2013-04-08       Impact factor: 6.514

4.  Formyl Peptide Receptor (FPR)1 Modulation by Resveratrol in an LPS-Induced Neuroinflammatory Animal Model.

Authors:  Rosa Calvello; Antonia Cianciulli; Chiara Porro; Piergianni Moda; Francesco De Nuccio; Giuseppe Nicolardi; Laura Giannotti; Maria Antonietta Panaro; Dario Domenico Lofrumento
Journal:  Nutrients       Date:  2021-04-23       Impact factor: 5.717

Review 5.  Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonists.

Authors:  Fabio Cattaneo; Melania Parisi; Rosario Ammendola
Journal:  Int J Mol Sci       Date:  2013-04-02       Impact factor: 5.923

6.  Deficiency of formyl peptide receptor 1 and 2 is associated with increased inflammation and enhanced liver injury after LPS-stimulation.

Authors:  Arne Giebeler; Konrad L Streetz; Oliver Soehnlein; Ulf Neumann; Ji Ming Wang; Lars-Ove Brandenburg
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

7.  Formyl peptide receptor as a novel therapeutic target for anxiety-related disorders.

Authors:  Irene Gallo; Lorenza Rattazzi; Giuseppa Piras; Thomas Gobbetti; Elisabetta Panza; Mauro Perretti; Jeffrey W Dalley; Fulvio D'Acquisto
Journal:  PLoS One       Date:  2014-12-17       Impact factor: 3.240

Review 8.  Cell-surface receptors transactivation mediated by g protein-coupled receptors.

Authors:  Fabio Cattaneo; Germano Guerra; Melania Parisi; Marta De Marinis; Domenico Tafuri; Mariapia Cinelli; Rosario Ammendola
Journal:  Int J Mol Sci       Date:  2014-10-29       Impact factor: 5.923

9.  The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis.

Authors:  Igor Snapkov; Carl Otto Öqvist; Yngve Figenschau; Per Kogner; John Inge Johnsen; Baldur Sveinbjørnsson
Journal:  BMC Cancer       Date:  2016-07-18       Impact factor: 4.430

10.  Amyloid-β(1-42) oligomer accelerates senescence in adult hippocampal neural stem/progenitor cells via formylpeptide receptor 2.

Authors:  N He; W-L Jin; K-H Lok; Y Wang; M Yin; Z-J Wang
Journal:  Cell Death Dis       Date:  2013-11-21       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.